# Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

> **NCT01942785** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 55 (actual)

## Conditions studied

- Major Depressive Disorder
- Irritability

## Interventions

- **DRUG:** Brexpiprazole

## Key facts

- **NCT ID:** NCT01942785
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2016-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942785, "Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01942785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*